UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells

PloS one, 2017-03, Vol.12 (3), p.e0173943-e0173943

2017

Volltextzugriff (PDF)

Hepatitis C virus fitness can influence the extent of infection-mediated epigenetic modifications in the host cells

Frontiers in cellular and infection microbiology, 2023-03, Vol.13, p.1057082-1057082

2023

Volltextzugriff (PDF)

Rate and Timing of Hepatitis C Virus Relapse after a Successful Course of Pegylated Interferon plus Ribavirin in HIV-Infected and HIV-Uninfected Patients

Clinical infectious diseases, 2009-11, Vol.49 (9), p.1397-1401

2009

Volltextzugriff (PDF)

Early monitoring of ribavirin plasma concentrations may predict anemia and early virologic response in HIV/hepatitis C virus-coinfected patients

Journal of acquired immune deficiency syndromes (1999), 2005-08, Vol.39 (4), p.401-405

2005

Volltextzugriff (PDF)

Peginterferon alpha-2a and ribavirin in patients with hepatitis C virus genotype 1 infection with persistently normal alanine aminotransferase levels

Journal of gastroenterology and hepatology, 2012-11, Vol.27 (11), p.1705-1710

2012

Volltextzugriff (PDF)

Management of betablocked patients after sustained virological response in hepatitis C cirrhosis

World journal of gastroenterology : WJG, 2019-06, Vol.25 (21), p.2665-2674

2019

Volltextzugriff (PDF)

Influence of HCV genotype and co-infection with human immunodeficiency virus on CD4+ and CD8+ T-cell responses to hepatitis C virus

Journal of medical virology, 2007-05, Vol.79 (5), p.503-510

2007

Volltextzugriff (PDF)

Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial

AIDS research and human retroviruses, 2007-08, Vol.23 (8), p.972-982

2007

Volltextzugriff (PDF)

Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C

AIDS (London), 2008-01, Vol.22 (1), p.15-21

2008

Volltextzugriff (PDF)

Incidence and Predictors of Severe Liver Fibrosis in Human Immunodeficiency Virus—Infected Patients with Chronic Hepatitis C: A European Collaborative Study

Clinical infectious diseases, 2004-01, Vol.38 (1), p.128-133

2004

Volltextzugriff (PDF)

Detection of hepatitis B virus genotype A3 and primary drug resistance mutations in African immigrants with chronic hepatitis B in Spain

Journal of antimicrobial chemotherapy, 2011-03, Vol.66 (3), p.641-644

2011

Volltextzugriff (PDF)

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

The New England journal of medicine, 2014-05, Vol.370 (20), p.1889-1898

2014

Volltextzugriff (PDF)

Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH)

Revista española de enfermedades digestivas, 2019-11, Vol.111 (11), p.862-873

2019

Volltextzugriff (PDF)

Management of hepatitis C in HIV-infected persons

Antiviral research, 2001-11, Vol.52 (2), p.189-198

2001

Volltextzugriff (PDF)

HCVerso3: An Open-Label, Phase IIb Study of Faldaprevir and Deleobuvir with Ribavirin in Hepatitis C Virus Genotype-1b-Infected Patients with Cirrhosis and Moderate Hepatic Impairment

PloS one, 2016-12, Vol.11 (12), p.e0168544

2016

Volltextzugriff (PDF)

HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals

Journal of acquired immune deficiency syndromes (1999), 2011-05, Vol.57 (1), p.1-8

2011

Volltextzugriff (PDF)

Changes in the distribution of hepatitis C virus (HCV) genotypes over time in Spain according to HIV serostatus: Implications for HCV therapy in HCV/HIV-coinfected patients

The Journal of infection, 2007-02, Vol.54 (2), p.173-179

2007

Volltextzugriff (PDF)

Liver complications have reached a plateau as cause of hospital admission and death in HIV patients in Madrid

AIDS research and human retroviruses, 2009-04, Vol.25 (4), p.383-385

2009

Volltextzugriff (PDF)

Hepatitis C virus (HCV) relapses after anti-HCV therapy are more frequent in HIV-infected patients

AIDS research and human retroviruses, 2004-04, Vol.20 (4), p.351-353

2004

Volltextzugriff (PDF)

Should We Treat Chronic Hepatitis C in HIV with Peginterferon Alpha 2a or 2b?

AIDS reviews, 2010-01, Vol.12 (1)

Garcia-Samaniego, J

2010

Volltextzugriff (PDF)

Management of chronic hepatitis C in patients co-infected with HIV: Focus on safety considerations

Drug safety, 2004, Vol.27 (1), p.7-24

2004

Volltextzugriff (PDF)

Virological characteristics of hepatitis C virus infection in HIV-infected individuals with chronic hepatitis C: implications for treatment

AIDS (London), 2002-02, Vol.16 (3), p.493-495

2002

Volltextzugriff (PDF)

Peginterferon Plus Ribavirin and Sustained Virological Response in HCV-Related Cirrhosis: Outcomes and Factors Predicting Response

The American journal of gastroenterology, 2010-10, Vol.105 (10), p.2164-2172

2010

Volltextzugriff (PDF)

Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients

AIDS research and human retroviruses, 2001-11, Vol.17 (16), p.1467-1471

2001

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Aktive Filter

ThemaHepatitis C Virus

ThemaScience & Technology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(40)
Mit Volltextzugriff
(33)

Publikationsform

Artikel
(41)

Sprache

Englisch
(41)
Spanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(37)
Humans
(35)
Human Immunodeficiency Virus
(29)
Infectious Diseases
(29)
Biological And Medical Sciences
(23)
Medical Sciences
(23)
Immunology
(22)
Antiviral Agents - Therapeutic Use
(21)
Male
(21)
Adult
(20)
Female
(20)
Hiv Infections - Complications
(19)
Human Viral Diseases
(19)
Viral Diseases
(19)
Hepatitis C
(18)
Hiv
(18)
Virology
(18)
Hepatitis C, Chronic - Drug Therapy
(17)

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

HCV coinfection contributes to HIV pathogenesis by increasing immune exhaustion in CD8 T-cells

Hepatitis C virus fitness can influence the extent of infection-mediated epigenetic modifications in the host cells

Rate and Timing of Hepatitis C Virus Relapse after a Successful Course of Pegylated Interferon plus Ribavirin in HIV-Infected and HIV-Uninfected Patients

Early monitoring of ribavirin plasma concentrations may predict anemia and early virologic response in HIV/hepatitis C virus-coinfected patients

Peginterferon alpha-2a and ribavirin in patients with hepatitis C virus genotype 1 infection with persistently normal alanine aminotransferase levels

Management of betablocked patients after sustained virological response in hepatitis C cirrhosis

Influence of HCV genotype and co-infection with human immunodeficiency virus on CD4+ and CD8+ T-cell responses to hepatitis C virus

Role of weight-based ribavirin dosing and extended duration of therapy in chronic hepatitis C in HIV-infected patients: the PRESCO trial

Undetectable hepatitis C virus RNA at week 4 as predictor of sustained virological response in HIV patients with chronic hepatitis C

Incidence and Predictors of Severe Liver Fibrosis in Human Immunodeficiency Virus—Infected Patients with Chronic Hepatitis C: A European Collaborative Study

Detection of hepatitis B virus genotype A3 and primary drug resistance mutations in African immigrants with chronic hepatitis B in Spain

Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

Elimination of hepatitis C. Positioning document of the Spanish Association for the Study of the Liver (AEEH)

Management of hepatitis C in HIV-infected persons

HCVerso3: An Open-Label, Phase IIb Study of Faldaprevir and Deleobuvir with Ribavirin in Hepatitis C Virus Genotype-1b-Infected Patients with Cirrhosis and Moderate Hepatic Impairment

HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals

Changes in the distribution of hepatitis C virus (HCV) genotypes over time in Spain according to HIV serostatus: Implications for HCV therapy in HCV/HIV-coinfected patients

Liver complications have reached a plateau as cause of hospital admission and death in HIV patients in Madrid

Hepatitis C virus (HCV) relapses after anti-HCV therapy are more frequent in HIV-infected patients

HIV Coinfection Predicts Failure of Ledipasvir/Sofosbuvir in Treatment-Naïve Noncirrhotic Patients With HCV Genotype 1

Should We Treat Chronic Hepatitis C in HIV with Peginterferon Alpha 2a or 2b?

Management of chronic hepatitis C in patients co-infected with HIV: Focus on safety considerations

Virological characteristics of hepatitis C virus infection in HIV-infected individuals with chronic hepatitis C: implications for treatment

Peginterferon Plus Ribavirin and Sustained Virological Response in HCV-Related Cirrhosis: Outcomes and Factors Predicting Response

Increasing impact of chronic viral hepatitis on hospital admissions and mortality among HIV-infected patients

Aktive Filter

Suchergebnisse filtern